Feasibility Study on Digital Tool for Chronic Myeloid Leukemia Patient Monitoring
Versailles Hospital is conducting a feasibility study to evaluate a digital monitoring tool for chronic myeloid leukemia patients who have discontinued treatment for up to 2 years. The study will assess the tool's usage rates over a 12-month period, with a threshold of 60% for feasibility.